To confirm database results, we evaluated the expression of LYVE‐1 in clinical paraffin embedded samples, revealing that patients with higher SOAT1 expression exhibited higher expression of LYVE‐1 in tumor tissues (Figure 5B). This evidence concerns the gene LYVE1 and neoplasm.